# Phase 1 Study of AWT020 in Advanced Cancer

> **NCT06092580** · PHASE1 · RECRUITING · sponsor: **Anwita Biosciences** · enrollment: 60 (estimated)

## Conditions studied

- Advanced Cancer

## Interventions

- **BIOLOGICAL:** AWT020

## Key facts

- **NCT ID:** NCT06092580
- **Lead sponsor:** Anwita Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-15
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06092580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06092580, "Phase 1 Study of AWT020 in Advanced Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06092580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*